Alkem Laboratories: The outcome of Board meeting dated 12th Nov, 2026. The meeting of the Board of Directors of the Company…
Alkem Laboratories (ALKEM) filed a disclosure titled "The outcome of Board meeting dated 12th Nov, 2026. The company is valued at about ₹62,473 crore.
What happened
Alkem Laboratories (ALKEM) filed a disclosure with the exchanges on 12 November 2026 at 01:50 PM titled "The outcome of Board meeting dated 12th Nov, 2026. The meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 13.40".
Company snapshot
Alkem Laboratories is a mid-cap company in the Healthcare sector, with a market value of about ₹62,473 crore.
The stock last traded at ₹5,225, against a 52-week range of ₹4,811–₹5,933.5 (11.9% below the high).
Before this filing the shares had moved +2.3% over the month and −2.3% over three months. Average daily turnover over the last 20 sessions was about ₹50.7 crore.
Promoters held 49.70% at the end of Q1 FY27, down 1.50% points from the previous quarter. Foreign institutions owned 10.42% and domestic institutions 22.63%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 3,371 | 664.3 | 55.56 |
| Q2 FY26 | 4,001 | 765.1 | 63.99 |
| Q3 FY26 | 3,737 | 636 | 53.19 |
| Q4 FY26 | 3,603 | 236.5 | 19.77 |
| Q1 FY27 | 3,740 | 520 | 43.49 |
What history shows
BCEIE's records show 6 previous board meeting filings from the company since May 2026.
After those filings, the stock fell 0.9% on average the next trading day and was down 1.9% on average after five days (5 filings with price data).
Across 92 similar disclosures by other Healthcare companies, shares moved +1.8% on average the next day and +2.6% over five days; 51% of them rose the next day.
Market-wide, 3,333 board meeting filings with an impact score of 50 or more saw an average next-day move of +0.0%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 4 Nov 2026 | Alkem Laboratories Ltdhas informed BSE that the meeting of the Board… | −0.9% | — |
| 14 Aug 2026 | , outcome of the Board Meeting held on 14th August, 2026 | −1.4% | −0.9% |
| 30 Jul 2026 | Disclosure Under Regulation 30 Of The Securities And Exchange Board… | −1.9% | −3.4% |
| 21 Jul 2026 | Board Meeting Intimation for Notice Of Meeting Of The Board Of… | −1.4% | −0.2% |
| 28 May 2026 | Board Meeting Outcome for Please Find Enclosed Herewith The Outcome… | +0.9% | −3.2% |
What to watch
- 12 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Alkem names former Zydus executive Dr Amrut Naik new CEO
- ALKEM Outlook for the Week
- Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Q2 2027 -- GF Value Sees 32% Upside
- Bipin Lokegaonkar Joins Alkem Laboratories as Chief Information Security Officer
- Tech Query: Alkem Laboratories, Intellect Design Arena, Trent, SRF — What is the outlook? Where are these stocks headed?
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.